Efficacy and safety of fondaparinux and enoxaparin for acute coronary syndromes in CKD

被引：0
|
作者：
Brophy, Donald F. [1 ]
机构：
[1] Virginia Commonwealth Univ, Coagulat Special Studies Lab, Dept Pharm, Richmond, VA 23298 USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2008年 / 51卷 / 05期
关键词：
D O I：
10.1053/j.ajkd.2008.02.002
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：719 / 723
页数：5
相关论文
共 50 条
  • [1] Comparison of fondaparinux and enoxaparin in acute coronary syndromes
    Yusuf, S
    Mehta, SR
    Bassand, JP
    Budaj, A
    Chrolavicius, S
    Fox, KAA
    Granger, CB
    Joyner, C
    Peters, RJG
    Wallentin, L
    Avezum, A
    Boden, W
    Cardona, E
    Ceremuzynski, L
    Col, J
    Commerford, PJ
    Diaz, R
    Faxon, D
    Flather, M
    Fodor, G
    Franzosi, MG
    Granger, C
    Halon, D
    Hunt, D
    Karatzas, N
    Keltai, M
    Kenda, M
    Kim, JH
    Lanas, F
    Lau, CP
    Lewis, BS
    Morais, J
    Moccetti, T
    Pais, P
    Paolasso, E
    Parkhomenko, A
    Petrauskiene, B
    Piegas, L
    Pipilis, A
    Robaayah, D
    Ruda, M
    Rumboldt, Z
    Rupprecht, HJ
    Sitkei, E
    Steg, PG
    Swahn, E
    Theroux, P
    Valentin, V
    Varigos, J
    Weitz, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (14): : 1464 - 1476
  • [2] Fondaparinux versus enoxaparin in acute coronary syndromes
    Majure, DT
    Aberegg, SK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (26): : 2829 - 2829
  • [3] Fondaparinux versus enoxaparin in acute coronary syndromes - Reply
    Yusuf, S
    Granger, CB
    Mehta, SR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (26): : 2830 - 2830
  • [4] Comparison in Terms of Safety and Efficacy between Fondaparinux and Enoxaparin in Acute Coronary Syndrome
    Kumar, Vinod
    Sharma, Kavita
    Bhagat, Ritu
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2019, 8 (31): : 2519 - 2522
  • [5] Fondaparinux versus enoxaparin in the management of acute coronary syndromes in Switzerland
    Kossovsky, Michel P.
    Keller, Pierre-Frederic
    Mach, Francois
    Gaspoz, Jean-Michel
    [J]. SWISS MEDICAL WEEKLY, 2012, 142
  • [6] Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non-ST-segment elevation acute coronary syndromes
    Fox, Keith A. A.
    Bassand, Jean-Pierre
    Mehta, Shamir R.
    Wallentin, Lars
    Theroux, Pierre
    Piegas, Leopoldo Soares
    Valentin, Vicent
    Moccetti, Tiziano
    Chrolavicius, Susan
    Afzal, Rizwan
    Yusuf, Salim
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 147 (05) : 304 - 310
  • [7] Efficacy and safety of fondaparinux versus Enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Results from the OASIS-5 trial
    Mehta, Shamir R.
    Granger, Christopher B.
    Eikelboom, John W.
    Bassand, Jean-Pierre
    Wallentin, Lars
    Faxon, David P.
    Peters, Ron J. G.
    Budaj, Andrzej
    Afzal, Rizwan
    Chrolavicius, Susan
    Fox, Keith A. A.
    Yusuf, Salim
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (18) : 1742 - 1751
  • [8] Fondaparinux in acute coronary syndromes
    Chaturvedi, Vivek
    Karthikeyan, Ganesan
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (12) : 1615 - 1623
  • [9] Comparison of Safety and Efficacy of Fondaparinux and Nadroparin in Non-ST Elevation Acute Coronary Syndromes
    Yan, Hongbing
    Song, Li
    Zhao, Hanjun
    Li, Wenzheng
    Liu, Chen
    Liu, Ran
    Zhou, Peng
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (8A): : 46A - 46A
  • [10] Enoxaparin in acute coronary syndromes
    Lee, Sinjin
    Gibson, C. Michael
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2007, 5 (03) : 387 - 399
12345